Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Anderson

Showing results (191-200 of 248) with videos related to

Pageof 25
Sort By:
The American Journal of Cardiology|April 1, 1987
Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoringD Levy, K M Anderson, J Plehn, et al.
Journal of Vascular Research|April 24, 1999
BMP-2 gene expression and effects on human vascular smooth muscle cellsR N Willette, J L Gu, P G Lysko, et al.
The American Journal of Cardiology|April 15, 1987
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart StudyD Levy, D D Savage, R J Garrison, et al.
Anticancer Research|August 23, 2000
A genomic response of H-358 bronchiolar carcinoma cells to MK 886, an inhibitor of 5-lipoxygenase, assessed with a cDNA arrayK M Anderson, W A Alrefai, P A Bonomi, et al.
The American Journal of Cardiology|September 1, 1987
Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart StudyD Levy, K M Anderson, D D Savage, et al.
The American Journal of Cardiology|November 14, 1997
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic ComplicationsK H Mak, R Challapalli, M J Eisenberg, et al.
In Vivo (Athens, Greece)|March 31, 2005
Reactive oxygen species and redox-induced programmed cell death due to MK 886: cells ("soil") "trump" agent ("seed")K M Anderson, M Rubenstein, W A Alrefai, et al.
Annals of Internal Medicine|January 1, 1988
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart StudyD Levy, K M Anderson, D D Savage, et al.
Journal of Vascular Surgery|May 8, 1999
A national survey of practice patterns in the noninvasive diagnosis of deep venous thrombosisJ Blebea, T K Kihara, M M Neumyer, et al.
Circulation|March 1, 1990
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophyD Levy, S B Labib, K M Anderson, et al.
Pageof 25

Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
The American Journal of Cardiology|April 1, 1987
Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoringD Levy, K M Anderson, J Plehn, et al.
Journal of Vascular Research|April 24, 1999
BMP-2 gene expression and effects on human vascular smooth muscle cellsR N Willette, J L Gu, P G Lysko, et al.
The American Journal of Cardiology|April 15, 1987
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart StudyD Levy, D D Savage, R J Garrison, et al.
Anticancer Research|August 23, 2000
A genomic response of H-358 bronchiolar carcinoma cells to MK 886, an inhibitor of 5-lipoxygenase, assessed with a cDNA arrayK M Anderson, W A Alrefai, P A Bonomi, et al.
The American Journal of Cardiology|September 1, 1987
Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart StudyD Levy, K M Anderson, D D Savage, et al.
The American Journal of Cardiology|November 14, 1997
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic ComplicationsK H Mak, R Challapalli, M J Eisenberg, et al.
In Vivo (Athens, Greece)|March 31, 2005
Reactive oxygen species and redox-induced programmed cell death due to MK 886: cells ("soil") "trump" agent ("seed")K M Anderson, M Rubenstein, W A Alrefai, et al.
Annals of Internal Medicine|January 1, 1988
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart StudyD Levy, K M Anderson, D D Savage, et al.
Journal of Vascular Surgery|May 8, 1999
A national survey of practice patterns in the noninvasive diagnosis of deep venous thrombosisJ Blebea, T K Kihara, M M Neumyer, et al.
Circulation|March 1, 1990
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophyD Levy, S B Labib, K M Anderson, et al.
Pageof 25